Takeda Pharmaceutical Company
Takeda Pharmaceutical Company Limited is a Japanese multinational biopharmaceutical company headquartered in Tokyo, founded in 1781 and listed on the Tokyo Stock Exchange (4502) and the New York Stock Exchange (TAK). It is the largest pharmaceutical company in Japan and Asia, and operates globally across oncology, rare genetic and hematologic diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines, a portfolio substantially expanded by its 2019 acquisition of Shire. Takeda is a software consumer rather than a software vendor: it runs large internal API and data platforms, but publishes no public developer program, API reference or machine-readable contract. The one machine-readable document it does serve to automated clients is an llms.txt at its corporate root, which indexes its verified country websites and states an explicit LLM usage and attribution policy.
Takeda Pharmaceutical Company is profiled on the APIs.io network. Tagged areas include Company, Pharmaceuticals, Healthcare, Life Sciences, and Biotechnology.
Takeda Pharmaceutical Company’s developer surface includes support, engineering blog, and 9 more developer resources.
Kin Score
Pricing Plans 1
Published pricing tiers and plan structures.
Rate Limits 1
Documented rate limits and quota policies.
Takeda Pharmaceutical Company Rate Limits
RATE LIMITSSecurity Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 1
Pagination, idempotency, versioning, errors, and events
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 1
Authentication, authorization, and security posture
Operate 2
Status, limits, changes, and where to get help
Commercial 3
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.